|
|
||||||||


,
Departments of
*
Biochemistry,
Microbiology and Immunology, and
Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461; and
Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843
The vesicular stomatitis virus (VSV) octapeptide RGYVYQGL binds to
H-2Kb and triggers a cytotoxic T cell response in mice. A
variant peptide, RGYVYEGL (E6) with a glutamic acid for glutamine
replacement at position 6 of the VSV peptide, elicits a T cell response
with features that are quite different from those elicited by the
wild-type VSV peptide. The differences found in the nature of the T
cells responding to the E6 peptide include changes in both the V
elements and the sequences of the complementarity-determining region 3
loops of their TCRs. Further experiments found that the E6 peptide can
act as an antagonist for VSV-specific T cell hybridomas. To determine
whether these differences in V
usage, complementarity-determining
region 3 sequences, and the switch from agonism to antagonism are
caused by a conformational change on the MHC, the peptide, or both, we
determined the crystal structure of the variant E6 peptide bound to
H-2Kb. This structure shows that the only significant
structural difference between H-2Kb/E6 and the previously
determined H-2Kb/VSV is limited to the side chain of
position 6 of the peptide, with no differences in the MHC molecule.
Thus, a minor conformational change in the peptide can profoundly alter
the biological outcome of the TCR-peptide/MHC
interaction.
This article has been cited by other articles:
![]() |
M. J. Miley, I. Messaoudi, B. M. Metzner, Y. Wu, J. Nikolich-Zugich, and D. H. Fremont Structural Basis for the Restoration of TCR Recognition of an MHC Allelic Variant by Peptide Secondary Anchor Substitution J. Exp. Med., December 6, 2004; 200(11): 1445 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Gakamsky, I. F. Luescher, and I. Pecht T cell receptor-ligand interactions: A conformational preequilibrium or an induced fit PNAS, June 15, 2004; 101(24): 9063 - 9066. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L.-D. de Cerio, J. J. Lasarte, N. Casares, P. Sarobe, M. Ruiz, J. Prieto, and F. Borras-Cuesta Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses Int. Immunol., June 1, 2003; 15(6): 691 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nilges, H. Hohn, H. Pilch, C. Neukirch, K. Freitag, P. J. Talbot, and M. J. Maeurer Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein J. Virol., May 1, 2003; 77(9): 5464 - 5474. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, S. Honda, F. Wang, T. P. DiLorenzo, A. M. Kalergis, D. A. Ostrov, and S. G. Nathenson Immunobiological Analysis of TCR Single-Chain Transgenic Mice Reveals New Possibilities for Interaction between CDR3{alpha} and an Antigenic Peptide Bound to MHC Class I J. Immunol., October 15, 2001; 167(8): 4396 - 4404. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |